Washington Trust Advisors, Inc. Baxter International Inc Transaction History

Washington Trust Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$53.86 - $66.8 $35,924 - $44,555	-667 Reduced 32.94%	1,358 $73,000
Q2 2022 Jul 25, 2022	SELL	$63.83 - $80.0 $109,404 - $137,120	-1,714 Reduced 45.84%	2,025 $130,000
Q1 2022 May 05, 2022	SELL	$76.85 - $89.45 $24,284 - $28,266	-316 Reduced 7.79%	3,739 $290,000
Q4 2021 Feb 11, 2022	BUY	$74.57 - $87.19 $302,381 - $353,555	4,055 New	4,055 $348,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.3B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.